Pemetrexed Disodium and Hsp90 Inhibitor AUY922 in Treating Patients With Previously Treated Stage IV Non-Small Cell Lung Cancer

NCT01784640 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Non-small Cell Lung Cancer
Squamous Cell Lung Cancer
Stage IV Non-small Cell Lung Cancer

Interventions

DRUG: Hsp90 inhibitor AUY922
DRUG: pemetrexed disodium
OTHER: pharmacological study
OTHER: laboratory biomarker analysis

Sponsor

Jonsson Comprehensive Cancer Center

Collaborators

[object Object]
[object Object]